Skip to search formSkip to main contentSkip to account menu

S 20098

Known as: S-20098, S20098 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

AcetamidesHypnotics and Sedatives

Narrower (3)

AgomelatineValdoxanthymanax

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC
Agomelatine is described as a novel and clinical effective antidepressant drug with melatonergic (MT1/MT2) agonist and 5-HT2C… 
2008
2008
Iconographies supplémentaires de l'article : Étude pilote comparant en aveugle l'effet thérapeutique de deux doses d'agomélatine, agoniste des récepteurs de la mélatonine et antagoniste des r…
Review
2005
Review
2005
C.09.01 Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system
Highly Cited
2003
Highly Cited
2003
[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].
RATIONALE AND METHOD Two doses of agomelatine (S-20098), a novel potential antidepressant drug with a new pharmacological profile… 
2000
2000
Photophysical studies on melatonin and its receptor agonists
Previous work has demonstrated that melatonin inhibits the growth of both dermal and uveal melanoma cells. Recent clinical trials… 
2000
2000
The melatonin agonist S20098, shift work and affective disorders
1999
1999
Organization of rat circadian rhythms during daily infusion of melatonin or S 20098 , a melatonin agonist
Pitrosky, B., R. Kirsch, A. Malan, E. Mocaer, and P. Pevet. Organization of rat circadian rhythms during daily infusion of… 
1998
1998
Resynchronisation of a diurnal rodent circadian clock accelerated by a melatonin agonist
USING ‘jet lag’ paradigms involving phase shifts in the light-dark (LD) cycle, we studied the effects of S-20098 on the circadian… 
1998
1998
Effects of early evening administration of the melatonin agonist S-20098 on hormonal profiles and sleep in normal older men
1994
1994
Trends in drug development for CNS disorders
Researchers are utilising a variety of approaches in the quest for more effective treatments for neurodegenerative diseases and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)